Nafamostat Mesilate for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

MLA

Yoo, Kyo-Sang, et al. “Nafamostat Mesilate for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.” Pancreas, vol. 40, no. 2, Mar. 2011, pp. 181–86. EBSCOhost, https://doi.org/10.1097/MPA.0b013e3181f94d46.

APA

Yoo, K.-S., Huh, K. R., Kim, Y. J., Kim, K. O., Park, C. H., Hahn, T., Park, S. H., Kim, J. H., Park, C. K., Kwon, Y.-J., & Lehman, G. A. (2011). Nafamostat Mesilate for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas, 40(2), 181–186. https://doi.org/10.1097/MPA.0b013e3181f94d46

Chicago

Yoo, Kyo-Sang, Kyung Rim Huh, Yu Jin Kim, Kyoung Oh Kim, Cheol Hee Park, Taeho Hahn, Sang Hoon Park, et al. 2011. “Nafamostat Mesilate for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.” Pancreas 40 (2): 181–86. doi:10.1097/MPA.0b013e3181f94d46.